biote Corp. (BTMD) Misses Q1 EPS by 51c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
Biote Reports First Quarter 2023 Financial Results
May 9, 2023 5:21 PM EDTNew Initiative Targets Long-term Growth Opportunity in Mens Health
Company Launches Warrant Exchange Offer and Consent Solicitation
Maintains 2023 Financial Guidance
IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the first quarter ended March 31,... More
